Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Validea
$12.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo Health Solutions Inc Sees FY 2012 EPS Guidance To Be At Or Below Low End Of Prior Range; Lowers FY 2013 Guidance


Wednesday, 12 Dec 2012 05:30am EST 

Endo Health Solutions Inc announced that it anticipates fiscal 2012 adjusted diluted earnings per share to be at or below the low end of its previous guidance range of $5.00 to $5.10. Additionally, the Company no longer expects to achieve its previous 2013 guidance for revenues of $3.0 to $3.2 billion and adjusted diluted earnings per share of $5.20 to $5.40. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $5.01 for fiscal 2012; EPS $5.20 for fiscal 2013. 

Company Quote

63.71
-0.31 -0.48%
29 Aug 2014